Cargando…
Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition
Numerous recurrent genetic mutations are known to occur in acute myeloid leukemia (AML). Among these common mutations, Fms-like tyrosine kinase 3 remains as one of the most frequently mutated genes in AML. We observed apparent marrow expansion of megakaryocytes in three out of six patients with Flt3...
Autores principales: | Suknuntha, Kran, Choi, Yoon Jung, Jung, Ho Sun, Majumder, Aditi, Shah, Sujal, Slukvin, Igor, Ranheim, Erik A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756118/ https://www.ncbi.nlm.nih.gov/pubmed/33363015 http://dx.doi.org/10.3389/fonc.2020.585151 |
Ejemplares similares
-
Generation of Human Neutrophils from Induced Pluripotent Stem Cells in Chemically Defined Conditions Using ETV2 Modified mRNA
por: Majumder, Aditi, et al.
Publicado: (2020) -
Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia
por: Horvat, Nathan P, et al.
Publicado: (2022) -
UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells
por: Mesquitta, Walatta-Tseyon, et al.
Publicado: (2019) -
SOX17 integrates HOXA and arterial programs in hemogenic endothelium to drive definitive lympho-myeloid hematopoiesis
por: Jung, Ho Sun, et al.
Publicado: (2021) -
Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells
por: Suknuntha, Kran, et al.
Publicado: (2015)